News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2021 Shelley Wood May 31, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Conference News ACC 2021 ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI Yael L. Maxwell May 15, 2021
News Conference News TCT 2019 Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA Michael O'Riordan September 28, 2019
Presentation TCT 2019 AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome Presenter: Stephan Windecker September 26, 2019
News Conference News ESC 2019 LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17 Todd Neale September 10, 2019
News Daily News DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit Todd Neale March 12, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Daily News Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines Todd Neale January 29, 2019
News Opinion Conversations in Cardiology Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? November 16, 2018
News Daily News DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus Caitlin E. Cox October 04, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2018 Shelley Wood April 02, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017